doi: 10.1007/BF00272379.
One haplotype is associated with the Swiss type of hereditary persistence of fetal hemoglobin in the Yugoslavian population
Affiliations
- PMID:2443439
- DOI: 10.1007/BF00272379
Item in Clipboard
One haplotype is associated with the Swiss type of hereditary persistence of fetal hemoglobin in the Yugoslavian population
G D Efremov et al. Hum Genet.1987 Oct.
Display options
Format
Display options
Format
Abstract
Blood samples from normal adults and from members of seven families with the Swiss type of hereditary persistence of fetal hemoglobin (HPFH) from Yugoslavia were analyzed for their fetal hemoglobin (Hb F) and G gamma levels, while haplotyping defined the chromosomes at eight or nine polymorphic restriction sites. The data indicate that Swiss-HPFH, characterized by slightly elevated Hb F and G gamma levels and no recognizable hematological abnormality, is associated with a chromosome whose restriction enzyme haplotype is identical to the no. 3 (Senegal) haplotype found in black sickle cell (SS) patients. Many adults with this chromosome have high G gamma but normal Hb F levels. It is suggested that the Swiss-HPFH phenotype results from the action of more than one factor; one is linked to the beta-globin gene cluster and causes high G gamma values, while others result in an increased Hb F production and are perhaps of different origins.
Similar articles
- Interaction of two different disorders in the beta-globin gene cluster associated with an increased hemoglobin F production: a novel deletion type of (G) gamma + ((A) gamma delta beta)(0)-thalassemia and a delta(0)-hereditary persistence of fetal hemoglobin determinant.Losekoot M, Fodde R, Gerritsen EJ, van de Kuit I, Schreuder A, Giordano PC, Vossen JM, Bernini LF.Losekoot M, et al.Blood. 1991 Feb 15;77(4):861-7.Blood. 1991.PMID:1704267
- Heterocellular hereditary persistence of fetal hemoglobin (HPFH). Molecular mechanisms of abnormal gamma-gene expression in association with beta thalassemia and linkage relationship with the beta-globin gene cluster.Giampaolo A, Mavilio F, Sposi NM, Carè A, Massa A, Cianetti L, Petrini M, Russo R, Cappellini MD, Marinucci M.Giampaolo A, et al.Hum Genet. 1984;66(2-3):151-6. doi: 10.1007/BF00286590.Hum Genet. 1984.PMID:6201431
- A frequent A gamma-hereditary persistence of fetal hemoglobin in northern Sardinia: its molecular basis and hematologic phenotype in heterozygotes and compound heterozygotes with beta-thalassemia.Ottolenghi S, Camaschella C, Comi P, Giglioni B, Longinotti M, Oggiano L, Dore F, Sciarratta G, Ivaldi G, Saglio G, et al.Ottolenghi S, et al.Hum Genet. 1988 May;79(1):13-7. doi: 10.1007/BF00291702.Hum Genet. 1988.PMID:2452784
- Delta beta thalassemia and hereditary persistence of fetal hemoglobin.Bollekens JA, Forget BG.Bollekens JA, et al.Hematol Oncol Clin North Am. 1991 Jun;5(3):399-422.Hematol Oncol Clin North Am. 1991.PMID:1713909Review.
- Interpreting elevated fetal hemoglobin in pathology and health at the basic laboratory level: new and known γ- gene mutations associated with hereditary persistence of fetal hemoglobin.Amato A, Cappabianca MP, Perri M, Zaghis I, Grisanti P, Ponzini D, Di Biagio P.Amato A, et al.Int J Lab Hematol. 2014 Feb;36(1):13-9. doi: 10.1111/ijlh.12094. Epub 2013 Apr 29.Int J Lab Hematol. 2014.PMID:23621512Review.
Cited by
- Characterization of chromosomes with hybrid genes for Hb Lepore-Washington, Hb Lepore-Baltimore, Hb P-Nilotic, and Hb Kenya.Lanclos KD, Patterson J, Efremov GD, Wong SC, Villegas A, Ojwang PJ, Wilson JB, Kutlar F, Huisman TH.Lanclos KD, et al.Hum Genet. 1987 Sep;77(1):40-5. doi: 10.1007/BF00284711.Hum Genet. 1987.PMID:2442092
- Compound heterozygosity for a beta zero-thalassemia (frameshift codons 38/39; -C) and a nondeletional Swiss type of HPFH (A----C at NT -110, G gamma) in a Czechoslovakian family.Indrak K, Indrakova J, Kutlar F, Pospisilova D, Sulovska I, Baysal E, Huisman TH.Indrak K, et al.Ann Hematol. 1991 Aug;63(2):111-5. doi: 10.1007/BF01707283.Ann Hematol. 1991.PMID:1716997
- Control of fetal hemoglobin: new insights emerging from genomics and clinical implications.Thein SL, Menzel S, Lathrop M, Garner C.Thein SL, et al.Hum Mol Genet. 2009 Oct 15;18(R2):R216-23. doi: 10.1093/hmg/ddp401.Hum Mol Genet. 2009.PMID:19808799Free PMC article.Review.
- Association between XmnI Polymorphism and HbF Level in Sickle Cell Disease Patients from Chhattisgarh.Bhagat S, Patra PK, Thakur AS.Bhagat S, et al.Int J Biomed Sci. 2012 Mar;8(1):36-9.Int J Biomed Sci. 2012.PMID:23675255Free PMC article.
- Association of Xmn1 -158 γG variant with severity and HbF levels in β-thalassemia major and sickle cell anaemia.Dadheech S, Jain S, Madhulatha D, Sharma V, Joseph J, Jyothy A, Munshi A.Dadheech S, et al.Mol Biol Rep. 2014 May;41(5):3331-7. doi: 10.1007/s11033-014-3195-5. Epub 2014 Feb 2.Mol Biol Rep. 2014.PMID:24488321